Evidence map›Paper›PMID 40855119›Full record

ArticleScientific reports2025

Characterization of genetic mutations in hepatitis B virus isolated from HBsAg+/HBcAb+/HBsAb-/HBV DNA + Japanese blood donors.

Ayako Sedohara, Kazuaki Takahashi, Takeya Tsutsumi, Keiko Arai, Fumio Nakahara, Kazuhiko Ikeuchi, Eisuke Adachi, Hiroshi Yotsuyanagi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayako SedoharaDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. sedohara@ims.u-tokyo.ac.jp.
Kazuaki TakahashiDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Takeya TsutsumiDepartment of Infectious Disease and Applied immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Keiko AraiDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Fumio NakaharaDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Kazuhiko IkeuchiDepartment of Infectious Disease and Applied immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Eisuke AdachiDepartment of Infectious Disease and Applied immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Hiroshi YotsuyanagiDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. yotsudid@ims.u-tokyo.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Japan, a universal hepatitis B (HB) vaccination was introduced in 2016. Through continuous analysis of HBV DNA mutations, the changes in HBV prevalence before and after the introduction of the universal HB vaccine can be monitored. In this study, we conducted mutational analysis of HBV DNA in HB small protein antigen-positive/HBV core antibody-positive/HB small protein antibody-positive/HBV DNA-positive donor blood samples, with the aim of establishing a baseline prior to the introduction of universal vaccination. We successfully sequenced the full-length HBV DNA in 32 of 33 samples. Immune-escape mutations in the S protein were frequently detected in genotypes B and C. In genotype B, a 1896 nonsense mutation in the precore protein-coding region, which enhances HBV replication and is associated with HB e antigen negativity, was detected at high frequency. In genotype A, the 1858 mutation, which suppresses the 1896 nonsense mutation, was detected at a high frequency. The 1762/1764 double mutation, a risk factor for hepatocellular carcinoma (HCC), was detected frequently in genotype C. These findings provide baseline data and indicate the need for continued monitoring to assess whether universal vaccination influences mutation patterns over time.

Indexed as

Blood DonorsDNA, ViralHepatitis BHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B virusMutationAdultEast Asian PeopleFemaleGenotypeHepatitis B Core AntigensHumansJapanMaleMiddle AgedDNA, ViralHepatitis B AntibodiesHepatitis B Core AntigensHepatitis B Surface AntigensCore promoter mutationFull-genome sequencingHepatitis b virusImmune escape mutationPrecore/core mutation

Identifiers

PMID40855119
PMCPMC12379280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.